Radiation Oncology Residents

PGY-5

John Michael "JM" Bryant, MD

Dr. Bryant is a resident physician at the University of South Florida and the H. Lee Moffitt Cancer Center and Research Institute. A core aspect of his work is integrating innovations from electrical and computer engineering into clinical oncology practices, underscoring his belief in the transformative potential of such interdisciplinary collaboration. He's dedicated to advancing oncology treatments and has been actively involved in research on MRI-guided radiotherapy to enhance the accuracy of cancer therapies. Furthermore, he has worked on developing deep neural networks to facilitate real-time biological treatment adaptation and has focused on the potential of magnetoelectric nanoparticles as novel theragnostic agents. Beyond his clinical and research pursuits, Dr. Bryant has showcased leadership both locally and nationally. He co-leads the Canopy Cancer Collective Resident & Fellow Committee, coordinating efforts across 14 leading cancer centers, and plays a vital role in expanding the outreach of the Association of Residents in Radiation Oncology.

Why I chose this residency program: I chose Moffitt Cancer Center because of the breadth of research and clinical opportunities paired with an institutional culture that prioritizes collegiality and interdisciplinary teamwork throughout the entire center. The staff prioritizes the education and mentoring of residents along with providing significant guidance and support in resident-led research. Furthermore, the combination of Moffitt’s high clinical volume and resident autonomy offers superb clinical training for my future career.

Online adaptive MRgRT: As a medical student performing research at the Miami Cancer Institute (MCI) and resident at MCC, my primary clinical research focus has been to explore safe delivery of ablative dose escalation, re-irradiation, and daily adaptive radiotherapy for tumors located next to radiosensitive normal structures to improve the local control rates of stereotactic external beam radiotherapy.

a.    Chuong MD, Bryant J, Mittauer KE, et al. Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided Radiation Therapy With On-Table Adaptive Replanning and Elective Nodal Irradiation for Inoperable Pancreas Cancer. Pract Radiat Oncol. Mar-Apr 2021;11(2):134-147. doi:10.1016/j.prro.2020.09.005

b.    Bryant JM, Palm RF, Liveringhouse C, et al. Surgical and Pathologic Outcomes of Pancreatic Adenocarcinoma (PA) After Preoperative Ablative Stereotactic Magnetic Resonance Image Guided Adaptive Radiation Therapy (A-SMART). Advances in Radiation Oncology. 2022;7(6)doi:10.1016/j.adro.2022.101045

c.    Chuong MD, Bryant JM, Herrera R, et al. Dose-Escalated Magnetic Resonance Image-Guided Abdominopelvic Reirradiation With Continuous Intrafraction Visualization, Soft Tissue Tracking, and Automatic Beam Gating. Adv Radiat Oncol. Mar-Apr 2022;7(2):100840. doi:10.1016/j.adro.2021.100840

d.    Bryant J, Palm RF, Herrera R, et al. Multi-Institutional Outcomes of Patients Aged 75 years and Older With Pancreatic Ductal Adenocarcinoma Treated With 5-Fraction Ablative Stereotactic Magnetic Resonance Image-Guided Adaptive Radiation Therapy (A-SMART). Cancer Control. 2023;30:10732748221150228. doi:10.1177/10732748221150228

DNN models for predicting clinical outcomes during radiotherapy: While performing research on online adaptive MRgRT, I have also aided in the development of proof-of-concept DNNs in and interdepartmental project involving the Departments of Radiation Oncology and Machine Learning using diagnostic imaging, daily MRIs acquired with online MRgRT, and clinical outcomes data to train several DNN models to determine if changes in tumor features during online MRgRT can predict for local and distant disease control. 

a.    P. Ghasemi Saghand, I. El Naqa, S. Rosenberg, J. Bryant, K. Latifi, J. Frakes, S. Hoffe, E. Moros. A Deep Learning Approach for Progression prediction using Morphological Changes in GTV During Treatment with MR-guided Radiation Therapy. 2022 Annual American Association of Physicists in Medicine (AAPM) Meeting

b.    J.M. Bryant, P.G. Saghand, Kujtim Latifi, J Frakes, S Hoffe, Eduardo Moros, Kathryn E. Mittauer, Rupesh Kotecha, I El Naqa, S.A. Rosenberg. A novel multi-task hybrid deep neural network (DNN) predicts tumor progression during MRgRT. 2023 Annual European Society for Radiotherapy and Oncology (ESTRO) Meeting (Oral Presentation)

Development of MENPs as onco-theragnostic tools in a preclinical model: During my undergraduate career, I developed experience with nanofabrication at the Florida International University and the University of California at Berkeley. I have brought this experience to help develop a multi-departmental initiative to perform pilot experiments exploring MENP use as a theragnostic agent:

1. High Specificity Anticancer Immune Response Treatment induced via Irreversible Electroporation with Magnetoelectric Nanoparticles in Pancreatic Cancer
2. In vivo magnetoelectric nanoparticles as a tumor-targeting contrast agent for T2 magnetic resonance imaging in a murine flank tumor model

Research:

1. Bryant JM, Cruz-Chamorro RJ, Gan A, et al. Structure-specific rigid dose accumulation dosimetric analysis of ablative stereotactic MRI-guided adaptive radiation therapy in ultracentral lung lesions. Communications Medicine. 2024/05/22 2024;4(1):96. doi:10.1038/s43856-024-00526-7
2. Bryant JM, Madey KC, Rosenberg SA, Frakes JM, Hoffe SE. Radiation Oncology Resident Education: Is Change Needed? Journal of Cancer Education. 2024/05/18 2024;doi:10.1007/s13187-024-02455-4
3. Bryant JM, Mills MN, Yang GQ, et al. Novel Definitive Hypofractionated Accelerated Radiation Dose-painting (HARD) for Unresected Soft Tissue Sarcomas. Advances in Radiation Oncology. 2024;9(4)doi:10.1016/j.adro.2024.101447
4. Bryant JM, Doniparthi A, Weygand J, et al. Treatment of Central Nervous System Tumors on Combination MR-Linear Accelerators: Review of Current Practice and Future Directions. Cancers. 2023;15(21):5200.
5. Bryant JM, Weygand J, Keit E, et al. Stereotactic Magnetic Resonance-Guided Adaptive and Non-Adaptive Radiotherapy on Combination MR-Linear Accelerators: Current Practice and Future Directions. Cancers (Basel). Mar 30 2023;15(7)doi:10.3390/cancers15072081

Ruben J. Cruz-Chamorro, MD

Ruben J. Cruz-Chamorro was born and raised in Ponce, Puerto Rico. He obtained a Bachelor’s degree in Biomedical Sciences at the University of Puerto Rico in Ponce. He was then accepted into Ponce Health Sciences University School of Medicine where he obtained both his Masters degree in Medical Sciences and his Doctorate in Medicine (MD). In his spare time, he enjoys songwriting, exploring new restaurants and spending time with family.

Why I chose this residency program: I chose Moffitt Cancer Center because education and training are a fundamental part of their core mission. The staff prioritizes the learning experience of residents at all times. Furthermore, the high clinical volume combined with the unlimited research opportunities makes Moffitt one of the fastest growing cancer centers in the world.

Research:

1. J.R. Gunther, C. Park, B. Dabaja, S.A. Milgrom, R. J. Cruz Chamorro, L.J. Medeiros, J. Khoury, N. Garg, B. Amini, R. Steiner, R. Nair, P. Strati, J.R. Westin, H. Lee, N. Fowler, L. Nastoupil, S.S. Neelapu, C.C. Pinnix. Radiation therapy for salivary gland MALT lymphoma: ultra-low dose treatment achieves encouraging early outcomes and spares salivary function. Leuk Lymphoma. 2019; PMID: 31373240.
2. C.C. Pinnix, J.R. Gunther, S.A. Milgrom, R. J. Cruz Chamorro, L.J. Medeiros, J. Khoury, B. Amini, S.S. Neelapu, H. Lee, J. Westin, N. Fowler, L. Nastoupil, B. Dabaja. Outcomes after Reduced-Dose Intensity Modulated Radiation Therapy for Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma. Int J Radiat Oncol Biol Phys. 2019; PMID: 30769175.
3. J.R. Gunther, C. Park, S.A. Milgrom, B. Dabaja, R. J. Cruz Chamorro, L.J. Medeiros, J. Khoury, N. Garg, B. Amini, M.A. Fanale, H. Lee, N. Fowler, L. Nastoupil, S.S. Neelapu, C.C. Pinnix. Radiation Therapy for Salivary Gland MALT Lymphoma: Ultra Low Dose Treatment Spares Salivary Function and Achieves Excellent Outcomes. Int J Radiat Oncol Biol Phys. 2018; 102(3): e244-e244.
4. C.C. Pinnix, J.R. Gunther, S.A. Milgrom, R. J. Cruz Chamorro, L.J. Medeiros, J. Khoury, B. Amini, M.A. Fanale, S.S. Neelapu, H. Lee, J. Westin, N. Fowler, L. Nastoupil, B. Dabaja. Excellent Outcomes after Reduced-Dose Intensity Modulated Radiation Therapy for Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma. Int J Radiat Oncol Biol Phys. 2018; 102(3): S90-90.

PGY-4

Emily Keit, MD

Emily was born in southern New Jersey but was raised primarily in Nebraska. She attended college at the University of Nebraska at where she studied biotechnology and chemistry. She attended medical school at University of Nebraska Medical Center. She completed her preliminary internal medicine year with University of South Florida and Moffitt. Interests outside of medicine include spending time in nature. 

Why I chose this residency program: I chose to do my training at Moffitt for many reasons. First, as an NCI Comprehensive Cancer Center, there are abundant research opportunities. Moffitt fosters a collaborative research environment between clinicians of all oncologic specialties, bench researchers, and computer modeling-based researchers. There is also an emphasis here on mentorship, and leadership strives to foster residents' individual interests and passions. I was confident that I would receive excellent clinical training and have the support needed to achieve my clinical and research-based goals.  Lastly, during my Internal Medicine intern year here, I was able to experience the overarching culture of Moffitt and the shared goals of providing personalized and holistic patient care. I am honored to be a part of this culture and community.

Vaseem Khatri, MD

Vaseem Khatri was born in New Jersey and raised in Rochester Hills, Michigan. He completed his undergraduate studies in Biomedical Physics at Wayne State University. He then attended the University of Cincinnati College of Medicine, followed by a preliminary year in Internal Medicine at The Christ Hospital in Cincinnati. In his free time, he enjoys dancing, watching movies, and spending time with his beautiful wife. 

Why I chose this residency program: I chose Moffitt Cancer Center because it fulfilled and exceeded every expectation for a residency program. The collegiality and support between residents, attendings, and staff, as well as across disciplines creates the optimal atmosphere. The leadership and the faculty take a true interest in the development of the residents as top-tier radiation oncologists, holistic physicians, and as humans. Additionally, Moffitt Cancer Center provides exceptional clinical and research opportunities. With its high patient volume, unique case load, extensive network, and available treatment modalities, it provides comprehensive training. Moffitt is on the forefront of radiation oncology research and has abundant opportunity and resources for its residents. Finally, Tampa is an excellent place to live, with unlimited activities, stellar year-round weather, and beautiful beaches and parks. 

Justyn Nakashima, DO

Justyn was born in Miami, FL and raised in Orlando, FL. He studied at the University of Central Florida majoring in Health Sciences and then attended Edward Via College of Osteopathic Medicine for medical school in Auburn, AL. He completed a preliminary medicine year at USF before starting his residency at Moffitt. In his free time, he loves to spend time with his wife and dog “Oslo”, explore new restaurants/breweries, go to the beach, play golf/soccer, go fishing, and travel.  

Why I chose this residency program: I was very impressed by the abundance of research opportunities and clinical training that Moffitt offers. As a high-volume center, I knew that Moffitt would provide excellent clinical exposure and give me the opportunity to see and treat rare cancers.  I was drawn to the program’s focus on personalized therapy utilized in both the clinical and research settings. The camaraderie between the residents and the resident-focused environment provided by the faculty made it an easy decision for me. 

PGY-3

Dekuang “DK” Zhao, DO, PhD 
 
Dekuang “DK” Zhao was born and raised in China. He completed the Cancer Biology graduate program at the University of Miami. He then attended medical school at Liberty University, followed by a preliminary year in Internal Medicine at the University of South Florida. Outside of medicine, he enjoys fishing, cooking, and spending time with his family on the beach.

Why I chose this residency program: I chose this program because of its high clinical volume, forefront research opportunities and supportive learning environment. As one of the leading cancer hospitals, Moffitt provides comprehensive cancer care to diverse patient populations across the nation, which gives residents abundant clinical exposure to various treatment modalities. Building upon Total Cancer Care, current research focusing on radiosensitivity index (RSI)-driven personalized radiation opens doors for a wide spectrum of clinical trials. Lastly and most importantly, the culture of mentoring and collaboration in our program fosters an excellent environment for residents’ academic and professional development.

Research:

1. Xiaoyu Jiang, XiaoQing Lu, Andrew J Gentles, Dekuang Zhao, Seth A. Wander, Yu Zhang, Yasodha Natkunam, Joyce Slingerland, Isildinha M. Reis, Brian Rabinovich, Midhat H. Abdulreda, Vincent T. Moy, Izidore S.Lossos, HGAL inhibits lymphoma dissemination by interacting with multiple cytoskeletal proteins. Blood Advances. 2021. Sep 20; bloodadvances.2021004304.
2. Yanxia Ma, Jonathan Shepherd, Dekuang Zhao, Lakshmi  Reddy Bollu, William M. Tahaney, Jamal Hill, Yun Zhang, Abhijit Mazumdar and Powel H. Brown. SOX9 Is Essential for Triple-Negative Breast Cancer Cell Survival and Metastasis. Mol Cancer Res. 2020, 18(12):1825-1838.
3. Hyunho Yoon, Minsoon Kim, Kibeom Jang, Miyoung Shin, Alexandra Besser, Xue Xiao, Dekuang Zhao, Seth A. Wander, Karoline Briegel, Lluis Morey, Andy Minn, and Joyce M. Slingerland. p27 transcriptionally coregulates cJun to drive programs of tumor progression. Proc Natl Acad Sci U S A. 2019, 116(14):7005-7014.
4. Dekuang Zhao, William M. Tahaney, Abhijit Mazumdar, Michelle I. Savage, Powel H. Brown. Molecularly Targeted Therapies for p53-mutant Cancers. Cell Mol Life Sci. 2017, 74(22):4171-4187.
5. Zhao D, Pan C, Sun C, Gilbert C, Drews-Elger K, Azzam DJ, Picon-Ruiz M, Kim M, Ullmer W, El-Ashry D, Creighton CJ, and Slingerland JM. VEGF drives cancer-initiating cells through VEGFR-2/STAT3 signaling to upregulate Myc and Sox2. Oncogene. 2015, 34(24):3107-3119.
6. Zhao D, Alexandra A*, Wander S, Sun J, Wang B, Ince T, Zhou W, Guo W, Mills G, Theodorescu D, Slingerland JM. Cytoplasmic p27 promotes epithelial-mesenchymal transition and tumor metastasis via STAT3-mediated Twist1 regulation. Oncogene. 2015, 34(43):5447-5459.  (*Equal contribution)
7. Jing Zhao, Dekuang Zhao, Graham M. Poage, Abhijit Mazumdar, Yun Zhang, Jamal L. Hill, Zachary C. Hartman, Michelle I. Savage, Gordon B. Mills, Powel H. Brown. Death-associated protein kinase 1 promotes growth of p53-mutant cancers. J Clin Invest. 2015, 125(7):2707-2720.

John Peterson, MD 
 
John Peterson grew up in Salt Lake City, Utah and completed both undergraduate and medical education at the University of Utah. He and his wife love exploring Tampa's cultural and culinary diversity with their baby boy.
 
Why I chose this residency program: It was important to me that I train at an NCI Comprehensive Cancer Center in the NCCN serving a large and diverse patient population. Moffitt is just that. I was also looking for an institution that was expanding and I wanted colleagues that were smart and supportive. While I was interacting with Moffitt residents and faculty, it was clear that this was a place that valued mutual respect, innovation, and professional development.
 
Research:
 

1. Peterson JS, Plana D, Bitterman DS, Johnson SB, Aerts HJ, Kann BH. Growth in eligibility criteria content and failure to accrue among National Cancer Institute (NCI)‐affiliated clinical trials. Cancer Med. 2023; 12:4715-4724. doi:10.1002/cam4.5276 
2. Peterson, J, Wilson, TF, Watt, MH, et al. International medical tourism of US cancer patients for alternative cancer treatments: Financial, demographic, and clinical profiles of online crowdfunding campaigns. Cancer Med. 2023; 00:1- 9. doi:10.1002/cam4.5636 
3. Peterson JS, Peckham ME, Poppe MM, Burt LS, Shrieve DC, Cannon DM. Delineating the Subarachnoid Space in the Adult Lumbosacral Spine Using Computed Tomographic Myelography: An Aid for Clinical Target Volume Delineation in Craniospinal Irradiation. Advances in Radiation Oncology. 2022;7(5):100994.
4. Peterson J, Wilson T, Gruhl J, et al. Timing and Motivations for Alternative Cancer Therapy With Insights From a Crowdfunding Platform: Cross-sectional Mixed Methods Study. JMIR Cancer. 2022;8(2):e34183. Published 2022 Jun 7. doi:10.2196/34183
5. Peterson J, Chow C, Bonnett R, Colbert-Getz J. Improving students' narrative feedback to educators. Med Educ. 2020;54(5):477-478. doi:10.1111/medu.14122
6. Hutten R, Khouri A, Parsons M, Tward A, Wilson T, Peterson J, et al. The Clinical Significance of Maximum Tumor Diameter on MRI in Men Undergoing Radical Prostatectomy or Definitive Radiotherapy for Locoregional Prostate Cancer. Clin Genitourin Cancer. 2022;20(6):e453-e459. doi:10.1016/j.clgc.2022.06.010
7. Parsons MW, Hutten RJ, Tward, Khouri A, Peterson J, et al. The Effect of Maximum Tumor Diameter by MRI on Disease Control in Intermediate and High-risk Prostate Cancer Patients Treated With Brachytherapy Boost. Clin Genitourin Cancer. 2022;20(1):e68-e74. doi:10.1016/j.clgc.2021.10.003
8. Peterson JS, Swire-Thompson B, Johnson SB. What is the alternative? Responding strategically to cancer misinformation. Future Oncol. 2020;16(25):1883-1888. doi:10.2217/fon-2020-0440

PGY-2

Celina Chiodo, MD

Celina Chiodo was born and raised in the Chicagoland area. As an undergraduate, she majored in Literature at Yale College. She completed a Masters in Medical Physiology and earned her Medical Doctorate at Loyola University Chicago Stritch School of Medicine. Prior to starting her residency training at Moffitt, she completed her preliminary year in Internal Medicine at Ascension Saint Francis Hospital in Evanston, Illinois. Outside of medicine, she enjoys music, movies, painting, orchid care, weightlifting and spending time with her two birds and her friends and family. 

Why I chose Moffitt: As I continue along my career path, it is important to me that I don't close any doors. I believe Moffitt will train me well for whichever path I take. There is a high clinical volume, an abundance of valuable research opportunities, an emphasis on mentorship and leadership, and a strong community for the residents, staff and patients. Here at Moffitt, I look forward to setting a strong foundation for a career of lifelong education and patient care.

Kolade Olabode, MD, MPH

Kolade was born and raised in Nigeria. He obtained his medical degree at the Olabisi Onabanjo University and practiced in Nigeria before moving to the US where he obtained his Master of Public Health at Kent State University, Ohio. He subsequently gained valuable pharmaceutical experience in oncology drug development, biostatistics and epidemiology before completing his preliminary year in surgery at the Nassau University Medical Center, New York. In his spare time, he enjoys spending time with his wife, family and friends; he is a huge soccer fan and likes to travel.

Why I chose Moffitt: I was impressed by the sheer volume of diverse clinical work, resources, infrastructure and research opportunities at Moffitt. The leadership and faculty are great and the emphasis on top-notch patient care, global health and innovate research is laudable. The culture at Moffitt was very instrumental in my choice and the multidisciplinary approach to healthcare delivery is phenomenal. Being at an NCI-designated Comprehensive Cancer Center was also a huge factor. 

Research:

1. Mohammad Khan, Clayton Hess, Tony Eng, Tahseen Nasti, Vishal Dhere, Troy Kleber, Jeffrey Switchenko, Brent Weinberg, Nadine Rouphael, Sibo Tian, Soumon Rudra, Kolade Olabode, Eileen Samuel, Rafi Ahmed. Combined Analysis of a Phase III Randomized Trial and Phase II Prospective Trial with Blind Control Matching of Patients Receiving Whole-Lung, Low-Dose Radiation for COVID-19: Full Results and Immunologic Correlates of the RESCUE 1-19 Trial. https://doi.org/10.1016/j.ijrobp.2023.06.1029. 2023.
2. Solomon O Badejoko, Jessie Wang, Paul E Formaker, Mojolaoluwa Balogun, Arshi Jha, Jessica B Madej, Mariam Akinwale, Kolade Olabode, Nso Nso, Raphael Ezeagu, Gurtej Malhi. S2304 Esophagobronchial Fistula After a Laparoscopic Partial Fundoplication, Mimicking as Empyema. http://dx.doi.org/10.14309/01.ajg.0000865856.09346.2b. 2022.
3. Kolade Olabode and Augustine Manadan, Ehizogie Edigin, Precious Eseaton, Chinenye Osuorji, Nneka Chukwu, Oluyemisi Amoda. Hospitalization for SLE Flare Has Reduced over Two Decades in the United States: A Longitudinal Population-based Study. American College of Rheumatology. 2021.
4. Macaulay Onuigbo, Kolade Olabode, Mohan Sengodan. ‘Sweet Hypoxia’ with Acute Kidney Injury: The Unpredictability of Acute Hypoxic Respiratory Failure in COVID-19 Infection – a Community Hospital Experience.  http://dx.doi.org/10.1093/ndt/gfab092.0048.  2021. 

Simran Alexandria Polce, MD

Simran Polce grew up on Long Island, NY. Her research at the VA Health system and The Feinstein Institute for Medical Research at Northwell Health nurtured her early interest in medicine. Dr. Polce earned her Bachelor of Science degree with summa cum laude honors from the New York Institute of Technology before obtaining her medical degree from Stony Brook University. She completed a preliminary year in internal medicine at North Shore University Hospital/Northwell Health, providing her with a solid foundation in general medicine. Outside of her medical career, Dr. Polce enjoys a variety of activities. She is an avid video game enthusiast and deeply appreciates Bollywood music. She values quality time spent with family and friends, which helps her maintain a balanced and fulfilling life.

Why I chose Moffitt: I chose Moffitt Cancer Center for my residency due to its exceptional clinical expertise, diverse staff and patient population, and outstanding research opportunities. The program's commitment to cutting-edge treatment techniques and its well-balanced training structure stood out to her. Additionally, the opportunity to work alongside incredible co-residents was a significant factor in my decision. I am passionate about personalized and holistic cancer care and strive to integrate these principles into my daily practice. 

Research:

1. Zabrocka E, Polce, S., Roberson JD, Wu J, Cohen J, Baer L, Stopeck A, Ryu S, Stessin A. Utility of Stereotactic Body Radiation Therapy in Establishing Local Control for Patients with Invasive Breast Cancer Not Undergoing Definitive Surgery. Int J Radiat Oncol Biol Phys. 2024 Feb 1;118(2):436-442. doi: 10.1016/j.ijrobp.2023.08.064. Epub 2023 Oct 2. PMID: 37793576.
2. Polce, S., Noldner C., Ailawadi S., Ryu S., Stessin A. Radiation Therapy in Cancer of Accessory Breast Tissue: Questions for Treatment Guidelines, Case Series, and Literature Review. Appl Rad Oncol. 2023;12(1):31-37.
3. Polce, S., Gogineni, E., Antone, J., Ghaly, M., Keith Frank, D., Segal, J. D., & Parashar, B. Dental radiation dosimetric maps from intensity-modulated radiation therapy planning for head and neck cancers. Head & Neck, 43(5), 1428–1439. https://doi.org/10.1002/hed.26611
4. Wernicke, A. G., Polce, S., & Parashar, B. Role of Radiation in the Era of Effective Systemic Therapy for Melanoma. The Surgical Clinics of North America, 100(1), 189–199. https://doi.org/10.1016/j.suc.2019.09.010
5. Polce, S. A., Burke, C., França, L. M., Kramer, B., de Andrade Paes, A. M., & Carrillo-Sepulveda, M. A. Ellagic Acid Alleviates Hepatic Oxidative Stress and Insulin Resistance in Diabetic Female Rats. Nutrients, 10(5), 531. https://doi.org/10.3390/nu10050531